Quote:
Originally Posted by jfman
Nobody gets anything courtesy of the UK here. They get it because they pay money. Astrazenica aren't doing this out the goodness of their hearts, they want to become the leading vaccine manufacturer worldwide for a product that requires billions of doses - that's without the consideration that it could become an annual affair. That requires initial investment (and sales) to ramp up capacity.
|
You really, really need to read the La Repubblica article.
There is an important sense in which the AstraZeneca vaccine actually is courtesy of the UK. AstraZeneca was handed a completed formula and a manufacturing process, all devised by Oxford University with funding from the UK government. AZ was given this on condition that it produce vaccine during the pandemic at cost. All it has had to do is use its expertise to scale up the recipe handed to it by Oxford.
Pascal Soirot explains all of this in interesting detail. Look, I've even scrolled back and found you the link:
https://www.repubblica.it/cronaca/20...nes-284349628/